Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients

Kidney International

Volumn 82, Issue 2, 2012, Pages 204-211

  Mc Causland, Finnian R ^a,b   Waikar, Sushrut S ^a,b   Brunelli, Steven M ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

diet; end stage renal disease; hemodialysis; mortality; sodium

Indexed keywords

ALBUMIN; CREATININE; SODIUM;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN INTAKE; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION;

EID: 84863299916     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.42     Document Type: Article

References (26)

1. Reinhardt HW, Seeliger E. Toward an integrative concept of control of total body sodium. News Physiol Sci 2000; 15: 319-325.
2. Simpson FO. Sodium intake, body sodium, and sodium excretion. Lancet 1988; 2: 25-29.
3. Kayikcioglu M, Tumuklu M, Ozkahya M et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009; 24: 956-962.
4. Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006; 21: 3506-3513.
5. Maduell F, Navarro V. Assessment of salt intake in hemodialysis. Nefrologia 2001; 21: 71-77.
6. KDOQI: KDOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45: S1-S153.
7. Dong J, Li Y, Yang Z et al. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol 2009; 5: 240-247.
8. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the national health and nutrition examination survey (NHANES I). Lancet 1998; 351: 781-785.
9. Elliott P, Stamler J, Nichols R et al. Intersalt revisited: further analyses of 24 h sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996; 312: 1249-1253.
10. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004; 3: CD004937.
11. Maduell F, Navarro V. Dietary salt intake and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 2063.
12. Krautzig S, Janssen U, Koch KM et al. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553.
13. Ang KS, Benarbia S, Boulahrouz R et al. Arterial hypertension in the hemodialysis patient. A model of salt-sensitive hypertension in man. Arch Mal Coeur Vaiss 1999; 92: 1023-1026.
14. Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 1255-1260.
15. Dennis B, Stamler J, Buzzard M et al. INTERMAP: the dietary data-process and quality control. J Hum Hypertens 2003; 17: 609-622.
16. McKeown NM, Day NE, Welch AA et al. Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort. Am J Clin Nutr 2001; 74: 188-196.
17. Reinivuo H, Valsta LM, Laatikainen T et al. Sodium in the Finnish diet: II trends in dietary sodium intake and comparison between intake and 24-h excretion of sodium. Eur J Clin Nutr 2006; 60: 1160-1167.
18. Pietinen P. Estimating sodium intake from food consumption data. Ann Nutr Metab 1982; 26: 90-99.
19. Greene T, Beck GJ, Gassman JJ et al. Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials 2000; 21: 502-525.
20. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019.
21. Miskulin DC, Athienites NV, Yan G et al. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 2001; 60: 1498-1510.
22. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560.
23. Brunelli SM, Chertow GM, Ankers ED et al. Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int 2010; 77: 630-636.
24. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008; 168: 656-664.
25. Brunelli SM, Joffe MM, Israni RK et al. History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 777-782.
26. Lynch KE, Lynch R, Curhan GC et al. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 620-629.